A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study)
| Image |  |
|---|---|
| Description | scientific article published on July 26, 2012 |
| Author/s | |
| Publication date | July 26, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
http://link.springer.com/content/pdf/10.1007/s10147-012-0437-1.pdf |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |